Cullinan Oncology
CGEM
CGEM
137 hedge funds and large institutions have $1.09B invested in Cullinan Oncology in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 67 increasing their positions, 28 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.93% more ownership
Funds ownership: 109.18% → 112.11% (+2.9%)
1% more funds holding
Funds holding: 135 → 137 (+2)
1% less capital invested
Capital invested by funds: $1.1B → $1.09B (-$10.3M)
Holders
137
Holding in Top 10
7
Calls
$11.1M
Puts
$2.1M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$13.8M | |
| 3 | +$13.2M | |
| 4 |
BlackRock
New York
|
+$13.2M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$13M |
Top Sellers
| 1 | -$19.6M | |
| 2 | -$19M | |
| 3 | -$18.5M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.7M |
| 5 |
PA
Perceptive Advisors
New York
|
-$13.1M |